Aldebaran Financial Inc. decreased its holdings in shares of Procter & Gamble Co (NYSE:PG) by 16.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 39,618 shares of the company’s stock after selling 7,525 shares during the period. Procter & Gamble makes up about 2.1% of Aldebaran Financial Inc.’s holdings, making the stock its 13th largest holding. Aldebaran Financial Inc.’s holdings in Procter & Gamble were worth $3,093,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of PG. Marshall & Sullivan Inc. WA bought a new stake in Procter & Gamble during the second quarter worth about $149,000. Clearwater Capital Advisors LLC bought a new stake in Procter & Gamble during the first quarter worth about $154,000. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in Procter & Gamble by 296.5% during the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 2,038 shares of the company’s stock worth $162,000 after purchasing an additional 1,524 shares during the last quarter. Financial Gravity Wealth Inc. bought a new stake in Procter & Gamble during the first quarter worth about $170,000. Finally, Clarus Wealth Advisors bought a new stake in Procter & Gamble during the second quarter worth about $172,000. 58.57% of the stock is owned by institutional investors.
In other Procter & Gamble news, insider Carolyn M. Tastad sold 19,791 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $92.71, for a total transaction of $1,834,823.61. Following the transaction, the insider now owns 60,575 shares in the company, valued at approximately $5,615,908.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Alexandra Keith sold 1,463 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The stock was sold at an average price of $89.89, for a total value of $131,509.07. Following the transaction, the insider now owns 45,018 shares in the company, valued at approximately $4,046,668.02. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 500,784 shares of company stock worth $46,237,322. 1.84% of the stock is owned by company insiders.
NYSE PG opened at $92.82 on Friday. Procter & Gamble Co has a 1-year low of $70.73 and a 1-year high of $94.81. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.80 and a quick ratio of 0.62. The stock has a market capitalization of $233.75 billion, a PE ratio of 22.00, a P/E/G ratio of 3.04 and a beta of 0.37.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 19th. The company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Procter & Gamble had a return on equity of 21.20% and a net margin of 15.10%. The company had revenue of $16.69 billion for the quarter, compared to the consensus estimate of $16.45 billion. During the same quarter in the previous year, the business earned $1.09 EPS. Procter & Gamble’s revenue was up .2% compared to the same quarter last year. Equities research analysts forecast that Procter & Gamble Co will post 4.41 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Friday, October 19th were issued a dividend of $0.7172 per share. The ex-dividend date of this dividend was Thursday, October 18th. This represents a $2.87 dividend on an annualized basis and a yield of 3.09%. Procter & Gamble’s dividend payout ratio is presently 68.01%.
PG has been the subject of several research analyst reports. Macquarie lifted their price target on Procter & Gamble from $86.00 to $92.00 and gave the stock an “outperform” rating in a research note on Monday, October 22nd. Societe Generale set a $87.00 target price on Procter & Gamble and gave the company a “hold” rating in a research note on Tuesday, October 23rd. TD Securities reissued a “hold” rating on shares of Procter & Gamble in a research note on Thursday, November 8th. UBS Group boosted their target price on Procter & Gamble from $82.00 to $87.00 and gave the company a “neutral” rating in a research note on Monday, October 22nd. Finally, Morgan Stanley set a $91.00 target price on Procter & Gamble and gave the company a “hold” rating in a research note on Monday, October 22nd. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $88.38.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/11/30/procter-gamble-co-pg-shares-sold-by-aldebaran-financial-inc.html.
Procter & Gamble Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
Featured Story: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.